Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.322% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1cc(C(=O)O)cc(NC(=O)c2cccs2)c1OC
b. Cc1cc(C)nc(NCCCN2CCOCC2)n1
c. CCC1CCCCN1CCCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
Answer: c. CCC1CCCCN1CCCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCCCN1CCCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
CCC1CCCCN1CCCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
N-[3-(2-ethylpiperidin-1-yl)propyl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide